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Axons in the mature mammalian central nervous system have only a limited 29 
capacity to grow/regenerate after injury, and, therefore, spontaneous recovery of motor 30 
functions is not greatly expected in spinal cord injury (SCI). To promote functional 31 
recovery after SCI, it is critical that corticospinal tract (CST) fibers reconnect properly 32 
with target spinal neurons through enhanced axonal growth/regeneration. Here, we 33 
applied antibody treatment against repulsive guidance molecule-a (RGMa) to a monkey 34 
model of SCI. We found that inhibition of upregulated RGMa around the lesioned site in 35 
the cervical cord resulted in recovery from impaired manual dexterity by accentuated 36 
penetration of CST fibers into laminae VII and IX where spinal interneurons and 37 
motoneurons are located, respectively. Furthermore, pharmacological inactivation 38 
following intracortical microstimulation revealed that the contralesional, but not the 39 
ipsilesional, primary motor cortex was crucially involved in functional recovery at a late 40 
stage in our SCI model. The present data indicate that treatment with the neutralizing 41 
antibody against RGMa after SCI is a potential target for achieving restored manual 42 





Manual dexterity as represented by a precision grip is skilled motor behavior 46 
characteristic of higher primates. It is generally accepted that manual dexterity is closely 47 
related to direct connectivity of the corticospinal tract (CST) arising from the motor 48 
cortex to motoneurons of the cervical cord that control the distal hand muscles (Lemon, 49 
1993). The spinal cord injury (SCI) disrupts the CST and often causes an ever-lasting 50 
disability with sensorimotor dysfunctions. Therefore, the CST has been focused as an 51 
essential target for SCI treatment (GrandPré et al., 2002; Oudega and Perez, 2012). 52 
However, the mature mammalian central nervous system (CNS) has only a limited 53 
capacity to grow/regenerate once injured because of a number of inhibitory factors, 54 
including axon guidance molecules (Yiu and He, 2006). 55 
Repulsive guidance molecule-a (RGMa) is among the axon guidance molecules. 56 
This molecule was originally identified in the visual system (Stahl et al., 1990; Monnier 57 
et al., 2002), and has been implicated in neuronal survival, proliferation and 58 
differentiation (Matsunaga et al., 2004; Matsunaga et al., 2006; Lah and Key, 2012). 59 
RGMa was upregulated around the lesioned site after SCI in rodents (Schwab et al., 60 
2005), and treatment with the neutralizing antibody against RGMa has been shown to 61 
accelerate axonal regrowth and sprouting from the CST following thoracic cord lesions 62 
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(Hata et al., 2006). On the other hand, to promote functional recovery by enhanced 63 
sprouting of CST fibers after CNS insults, such fibers are required to extend toward an 64 
appropriate locus and reconnect properly with target spinal neurons (Wahl et al., 2014). It 65 
has recently been reported in macaque monkeys that a number of sprouting CST fibers 66 
derived from the contralesional primary motor cortex (MI) after SCI penetrate, below the 67 
lesioned site, into laminae VII and IX where spinal interneurons and motoneurons are 68 
located, respectively. Moreover, the ratio of the axonal distribution was significantly 69 
increased in lamina IX (Nakagawa et al., 2015). By contrast, the sprouting CST fibers 70 
chiefly terminate within the medial gray matter in rodents (Hata et al., 2006; Vavrek et al., 71 
2006). These results suggest that the mechanisms underlying axonal remodeling that 72 
leads to the recovery of motor functions after SCI may differ in higher primates and 73 
rodents. Therefore, it is important to understand axonal remodeling specific to higher 74 
primates for restoration of manual dexterity after SCI. It is also crucial to confirm 75 
whether RGMa suppression promotes the recovery from impaired manual dexterity for 76 
applying to human patients with SCI. 77 
The present study aimed at establishing the antibody treatment against RGMa in 78 
higher primates. Our results indicate that treatment with the neutralizing antibody against 79 




Materials and Methods 82 
Animals 83 
Twelve rhesus monkeys (Macaca mulatta, 3–5 years old, 3.8–5.4 kg) of either 84 
sex were used in the present study: three lesioned monkeys for treatment with control 85 
antibody (Ctrl-A to Ctrl-C), four monkeys for treatment with anti-RGMa antibody 86 
(RGMa-A to RGMa-D), and five normal monkeys for molecular biological (western 87 
blotting) and histological (histochemical, immunohistochemical, and in situ 88 
hybridization) analyses. The experimental protocols were approved by the Animal 89 
Welfare and Animal Care Committee of the Primate Research Institute, Kyoto 90 
University, Japan. All experiments were conducted in accordance with the Guide for 91 
Care and Use of Laboratory Primates (Ver. 3, 2010) by the Primate Research Institute, 92 
Kyoto University, Japan. 93 
 94 
Anti-RGMa antibody 95 
We used an anti-human RGMa antibody (mouse IgG; IBL) as a neutralizing 96 
antibody against RGMa in the present study. The antibody was raised against the 97 
C-terminal sequences of human RGMa, LYERTRDLPGRAAAGL. The protein 98 
sequence of human RGMa fully corresponds with that for macaque monkeys. It has 99 
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previously been reported that the antibody has an inhibitory effect on human RGMa 100 
obtained from peripheral blood mononuclear cells of human patients with multiple 101 
sclerosis (Muramatsu et al., 2011). 102 
 103 
Western blotting 104 
Following sedation with ketamine hydrochloride (10 mg/kg, i.m.) and xylazine 105 
hydrochloride (1 mg/kg, i.m.), an intact monkey was anesthetized deeply with sodium 106 
pentobarbital (50 mg/kg, i.v.) and perfused transcardially with 0.1 M 107 
phosphate-buffered saline (PBS; pH 7.4). The MI (digit region) and the spinal cord (C7 108 
to Th1 segments) were harvested and homogenized in a lysis buffer, comprising 50 mM 109 
Tris-HCl (pH 7.8) with 150 mM NaCl, 1 mM EDTA, 2 mM Na3VO4, 1% NP-40, and 110 
protease inhibitor cocktail. After centrifugation at 13,000 g for 20 min at 4˚C, it was 111 
lysed by using equal amounts of 2 x sample buffer, comprising 250 mM Tris-HCl, 4% 112 
sodium dodecyl sulphate, 20% glycerol, 0.02% bromophenol blue, and 5% 113 
β-mercaptoethanol, and then proteins were boiled for 5 min at 95˚C. The mixed proteins 114 
were separated on sodium dodecyl sulphate polyacrylamide gel electrophoresis and 115 
transferred to a polyvinylidence fluoride membrane (Millipore). The membrane was 116 
blocked with 5% skim milk in 0.01 M PBS containing 0.05% Tween-20 and then 117 
9 
 
incubated with anti-RGMa antibody (IBL). After several washes, the membrane was 118 
incubated with horseradish peroxidase-linked anti-mouse IgG antibody (1:5,000; Cell 119 
Signaling Technology). The detection was carried out with an ECL chemiluminescence 120 
system (GE Healthcare). As control samples, human- and mouse-recombinant RGMa 121 
proteins (R & D systems) were used. 122 
 123 
Experimental time-course 124 
The experimental time-course was summarized in Figure 1N. The monkeys 125 
were trained with the two behavioral tasks, a reaching/grasping task and a modified 126 
Brinkman board test (Freund et al., 2006, 2009) for 2–3 months prior to SCI. To reduce 127 
the inter-animal variability in the modified Brinkman board test, pairs of monkeys who 128 
exhibited similar baselines before SCI (i.e., Ctrl-A and RGMa-A, Ctrl-B and RGMa-B, 129 
and Ctrol-C and RGMa-C) usually underwent simultaneous behavioral analyses. After 130 
SCI, the two behavioral tasks were performed to assess the extent of recovered forelimb 131 
movements over 14 weeks. Following all behavioral analyses, the digit regions of the 132 
contralesional and ipsilesional MI were identified in the anti-RGMa antibody-treated 133 
monkeys using intracortical microstimulation (ICMS), and then muscimol was injected 134 
into the identified digit regions to inactivate neuronal activity therein. To examine 135 
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sprouting CST fibers below the lesioned site, biotinylated dextran amine (BDA) was 136 
injected into the contralesional MI seven weeks prior to sacrifice. To label spinal 137 
motoneurons through the median nerve on the SCI side, wheat germ 138 
agglutinin-conjugated horseradish peroxidase (WGA-HRP) was infused from the cut 139 
end of the nerve four days prior to sacrifice. One of the four monkeys (RGMa-B) who 140 
were treated with the anti-RGMa antibody was excluded from the 141 
electrophysiological/pharmacological and histological analyses, because this monkey 142 
was dead by unknown accident shortly after the behavioral analyses. 143 
 144 
Behavioral analyses 145 
We investigated whether RGMa inhibition with the antibody might promote the 146 
recovery from impaired manual dexterity after SCI. To assess the extent to which the 147 
skilled motor behavior was restored in our SCI model, the two behavioral tasks, a 148 
reaching/grasping task and a modified Brinkman board test were performed. These tasks 149 
were designed to take out pellets from vertical and horizontal slots. Each behavioral 150 
analysis was carried out on the 3rd, 5th, 7th, and 10th day after SCI, and then twice a 151 




Reaching/grasping task 154 
This task was performed to assess quantitatively the extent of recovery of 155 
dexterous manual movements as previously described (Nakagawa et al., 2015). Briefly, 156 
the monkeys were seated in a primate chair, and an acrylic board which consisted of 157 
three vertical or horizontal slots was placed in front of the chair (Fig. 4A,B). Each slot 158 
was filled with a small pellet (diameter, 9 mm). The monkeys reached for the vertical or 159 
horizontal slots and attempted to pick up three pellets within 10 sec in each trial. We 160 
analyzed how many pellets the monkeys successfully collected in each session (7 trials). 161 
Data were expressed as the ratio of the number of collected pellets to the total number 162 
per session (21 pellets; 3 pellets x 7 trials) in each of the vertical-slot and horizontal-slot 163 
tasks. 164 
 165 
Modified Brinkman board test 166 
The Brinkman board test was originally created to assess manual dexterity after 167 
SCI at the cervical cord level in macaque monkeys (Rouiller et al., 1998). Later, Freund 168 
et al. (2006, 2009) have made a minor modification for analyzing the extent of 169 
functional recovery from SCI, and named it “a modified Brinkman board test”. In the 170 
present study, we applied this modified version. The monkeys were seated in a primate 171 
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chair, and the Brinkman board was placed on the chair. The Brinkman board (10 cm x 172 
20 cm) was made of an acrylic board where a total of 50 slots (15 mm long x 8 mm 173 
wide x 6 mm deep), consisting of 25 vertical and 25 horizontal slots, were randomly 174 
located on the board (Fig. 4E). Each slot was filled with a food pellet (94 mg, banana or 175 
very berry flavor; Bioserve). In our modified Brinkman board test, each session 176 
consisted of 50 trials (25 trials for each of the vertical- and horizontal-slot tasks) to take 177 
out a total of 50 pellets, and a trial was considered to be successful when the monkey 178 
grasped a pellet and conveyed it to the mouth within 30 sec. On the other hand, a trial 179 
was counted as an error when the monkey failed to grasp a pellet or dropped it on the 180 
way to the mouth. The baseline value prior to SCI was represented as the mean of 181 
successful trials (maximum = 25) per session in each of the vertical- and horizontal-slot 182 
tasks that were performed 7 times (5 sessions per day). In each monkey, the analyzed 183 
data were evaluated as the number of successful trials per session in a daily test. 184 
 185 
Surgical procedures for SCI 186 
Surgical procedures for SCI were performed as previously described with 187 
minor modifications (Nakagawa et al., 2015). Briefly, the monkeys were sedated with a 188 
combination of ketamine hydrochloride (10 mg/kg, i.m.), xylazine hydrochloride (1 189 
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mg/kg, i.m.), and atropine (0.05 mg/kg, i.m.), and then anesthetized with sodium 190 
pentobarbital (25 mg/kg, i.v.). The monkeys who were monitored with percutaneous 191 
oxygen saturation, respiration rate, heart rate, blood pressure, body temperature, and 192 
electrocardiogram were stabilized in a stereotaxic frame. The skin and axial muscles 193 
were dissected at the level of the C2 to T1 segments under aseptic conditions. 194 
Subsequently, laminectomy of the C3 to C7 segments was performed, and the dura 195 
mater was cut unilaterally. After identification of the dorsal roots at the C6 and C7 196 
levels, a border between the C6 and the C7 segment was lesioned with a surgical blade 197 
(No. 11) and a special needle (27G). The anti-RGMa antibody or control antibody (IgG 198 
from mouse serum; Sigma-Aldrich) was continuously delivered, via an osmotic pump 199 
(2ML4, Alzet) installed under the skin of the back, to the periphery of the lesioned site 200 
over four weeks immediately after SCI. Both the anti-RGMa and the control antibodies 201 
purified as IgGs were concentrated to 50 μg/kg/day in PBS. To estimate the extent of 202 
antibody infusion in the spinal cord, a 1% solution of Fast blue (Polysciences) was used 203 
instead of the antibody. To fix properly a catheter (11 cm long) attached to the osmotic 204 
pump, the top of the catheter was placed 5 mm above the lesioned site under the dura 205 
mater (intrathecal administration) following SCI, and the catheter was connected to the 206 
dura mater and surrounding muscles with surgical suture to keep the position during the 207 
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delivery of the antibody (Fig. 1K). Subsequently, spongel (Astellas) was located on the 208 
dura mater for hemostasis, and then the muscles and skin were sutured. Following the 209 
surgery, the monkeys were given an analgesic (Lepetan; Otsuka; i.m.; Indomethacin; 210 
Isei; oral, one week) and an antibiotic (Viccillin; Meiji Seika; i.m., 3–4 days). Four 211 
weeks later, the osmotic pump was removed from the back under general anesthesia 212 
(see above) and, then, checked to ensure that the whole amount of the antibody was 213 
certainly delivered up. 214 
 215 
Intracortical microstimulation (ICMS) 216 
Under general anesthesia with sodium pentobarbital (25 mg/kg, i.v.), two pipes 217 
made of polyether ether ketone were mounted in parallel over the frontal and occipital 218 
lobes for head fixation. After partial removal of the skull over the central sulcus under 219 
aseptic conditions, two rectangular plastic chambers (for the contralesional MI, 37 mm 220 
long x 42 mm wide x 15 mm deep; for the ipsilesional MI, 28 mm long x 32 mm wide x 221 
20 mm deep) were attached to the exposed skull. Several days later, each monkey was 222 
seated in a primate chair with the head fixed in a stereotaxic frame attached to the chair. 223 
A glass-coated tungsten microelectrode (0.5–1.5 MΩ at 1 kHz; Alpha Omega) was 224 
penetrated perpendicularly into the contralesional or ipsilesional MI to identify the digit 225 
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region. Parameters of electrical stimulation were as follows: trains of 11 and 44 cathodal 226 
pulses, 200-µsec duration at 333 Hz, current of less than 65 µA. Basically, movements 227 
of the digits on the MI stimulation are easily elicited by short trains in a normal control 228 
(Miyachi et al., 2005). However, as we could assume that the movement threshold for 229 
ICMS might become higher after SCI, we used a 44-pulse train in addition to a 11-pulse 230 
train. Evoked movements of the digits were carefully monitored by visual inspection 231 
and muscle palpation. 232 
 233 
Muscimol injections 234 
To confirm whether compensatory pathways arising from the contralesional MI 235 
might be involved in recovery from impaired manual dexterity in our SCI model, the 236 
gamma-aminobutyric acid type A (GABAA) receptor agonist, muscimol (1 μg/μl in 237 
physiological saline, Sigma-Aldrich), was injected into the 238 
electrophysiologically-identified digit region of the contralesional or ipsilesional MI 239 
through a 10-μl Hamilton microsyringe following ICMS. At each of four loci, 3 μl of 240 
muscimol was very slowly infused (Fig. 6A). Saline was injected into the same sites 241 
using the same parameters as a control. After the muscimol or saline injections into the 242 
MI digit region, skilled forelimb movements were assessed with the reaching/grasping 243 
16 
 
task (for horizontal slots). Data were expressed as the ratio of successfully collected 244 
pellets to the total per session. 245 
 246 
Anterograde tract-tracing of CST fibers 247 
CST fibers below the lesioned site arising from the contralesional MI were 248 
anterogradely labeled with biotinylated dextran amine (BDA; Invitrogen; 10,000 MW). 249 
The BDA injections into the contralesional MI were performed seven weeks prior to 250 
sacrifice as previously described (Nakagawa et al., 2015). Briefly, under general 251 
anesthesia (see above), a 10% solution of BDA in PBS was extensively injected into 252 
multiple loci along the central sulcus where regions representing not only the forelimb, 253 
but also the trunk and hindlimb were located, through a 5-μl Hamilton microsyringe 254 
(150 nl each penetration) (Fig. 1B). 255 
 256 
Motoneuron labeling through the median nerve 257 
To label spinal motoneurons through the median nerve on the SCI side, a 5% 258 
solution of WGA-HRP in physiological saline (Sigma-Aldrich) was applied to the cut 259 
end of the nerve four days prior to sacrifice. Under deep-anesthesia conditions (see 260 
above), the skin and intermuscular septum of the arm were dissected, and the median 261 
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nerve was exposed. The nerve was fully transected approximately 3.5 cm distal to the 262 
elbow joint. A total of 10 μl WGA-HRP was put inside a special tube, the cut end of the 263 
nerve was immersed in the tracer solution for 10 min, and then, the muscles and skin 264 
were sutured. Following the surgery, the monkeys were given the analgesic and 265 
antibiotic. 266 
 267 
Histochemical and immunohistochemical procedures 268 
Following sedation with ketamine hydrochloride (10 mg/kg, i.m.) and xylazine 269 
hydrochloride (1 mg/kg, i.m.), the monkeys were anesthetized deeply with sodium 270 
pentobarbital (50 mg/kg, i.v.) and perfused transcardially with 10% formalin. The fixed 271 
brain and spinal cord were removed, immersed in PBS containing 30% sucrose until 272 
they sank, and then cut serially into 40-μm thick transverse sections (for the spinal cord) 273 
or 50-μm thick frontal sections (for the brain) on a freezing microtome. Procedures for 274 
histochemical visualization of injected and transported BDA with DAB-nickel and for 275 
immunohistochemistry with the Vector NovaRed substrate kit (Vector laboratories) were 276 
done as described elsewhere (Nakagawa et al., 2015). For immunofluorescence 277 
histochemical procedures, floating sections were blocked with 2% normal goat or 278 
donkey serum and 3% bovine serum albumin in PBS containing 0.1% Triton X-100 for 279 
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60 min. The sections were then incubated with primary antibodies for 120 min at room 280 
temperature (RT), followed by two overnights at 4°C. Primary antibodies used in the 281 
present study were as follows: mouse anti-RGMa (IBL), rabbit anti-Iba1 (Wako), goat 282 
anti-ChAT (Millipore), mouse anti-NeuN (Millipore), goat anti-WGA (Vector 283 
laboratories), rabbit anti-WGA (Sigma-Aldrich), guinea pig anti-VGluT1 (Millipore), 284 
and sheep anti-Chx10 (Abcam) antibodies. The anti-WGA antibody was pre-absorbed 285 
with powder of the monkey’s brain and spinal cord for prevention of cross-reaction with 286 
unknown endogenous molecules. The goat anti-WGA antibody was used for all analyses 287 
except double immunostaining with the rabbit anti-WGA antibody in combination with 288 
the goat anti-ChAT antibody. BDA immunofluorescence histochemistry was carried out 289 
with Alexa Fluor 488-conjugated streptavidin two overnights at 4°C. Subsequently, the 290 
sections were incubated with secondary antibodies for 120 min at RT in the dark. 291 
Secondary antibodies used in this study were as follows: goat and donkey anti-mouse, 292 
rabbit, goat, guinea pig, and sheep IgG Alexa Fluor 647, 568, and 488 (Invitrogen). To 293 
reduce endogenous autofluorescence, the sections were immersed in a TrueBlack 294 
(Biotium) solution diluted by 70% ethanol for 30 sec. All histochemical and 295 
immunohistochemical images were acquired with a microscope (Biorevo BZ-9000, 296 
Keyence) or a confocal laser-scanning microscope (Fluo View FV1000, Olympus and 297 
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LSM 800, Zeiss). 298 
 299 
In situ hybridization procedures 300 
Under deep anesthesia (see above), the monkeys underwent perfusion-fixation 301 
with 4% paraformaldehyde (PFA) dissolved in 0.1 M phosphate buffer (PB; pH 7.4). 302 
The brain was removed and immersed in a 30% sucrose solution containing 4% PFA at 303 
4˚C overnight. In situ hybridization was performed as previously described with minor 304 
modifications (Watakabe et al., 2007). Briefly, 40-μm-thick frontal sections were placed 305 
onto glass slides (Thermo Fisher Scientific) and fixed with 4% PFA in PB for 15 min at 306 
RT. The sections were treated sequentially with proteinase K (7.2 μg/ml) for 30 min at 307 
37˚C, 4% PFA for 15 min at RT, 0.25% acetic anhydride in 0.1 M triethanolamine for 10 308 
min at RT, 0.3% Triton X-100 in PB for 20 min at RT. Subsequently, the sections were 309 
hybridized with a Digoxigenin (DIG)-labeled riboprobe (0.12 μg/ ml) for 16 hr at 68˚C 310 
in a hybridization buffer comprising 50% formamide, 5x SSC, 5x Denhard’s solution 311 
(Invitrogen), 250 μg/ml tRNA (Roche Diagnostics), 500 μg/ml ssDNA (Sigma-Aldrich). 312 
The riboprobe for Neogenin (XM_015142632.1; 346–979) was purchased from Geno 313 
Staff (Tokyo, Japan) and heated at 80˚C for 5 min before use. After overnight, the 314 
sections were washed with 0.2x SSC for 30 min x 3 at 68˚C. Next, the sections were 315 
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blocked with 1% blocking reagent (Roche Diagnostics) and 10% lamb serum in 316 
Tris-buffered saline containing 0.05% Tween 20 (TBS) for 1 hr at RT and then 317 
incubated with alkaline phosphatase-conjugated anti-DIG antibody (1:5,000 dilution, 318 
Roche Diagnostics) in TBS containing 1% blocking reagent and 1% lamb serum for 2 hr 319 
at RT. To visualize hybridization signals, the sections were immersed in a coloring 320 
buffer containing nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. 321 
 322 
Data analyses 323 
Quantification of BDA-labeled CST fibers below the lesioned site 324 
BDA-labeled CST fibers in the C7, C8, and Th1 segments were quantified in 325 
laminae VII and IX of transverse sections (400 μm apart) on the SCI side. Additionally, 326 
BDA-labeled midline-crossing fibers from the ipsilateral and ventral CSTs were 327 
quantified in each segment below the lesioned site. In lamina VII, the intensity of 328 
BDA-labeled CST fibers stained by DAB reaction was measured within a rectangular 329 
area (273 μm high x 362 μm wide) that was located 800 μm lateral to the center of the 330 
central canal using an ImageJ software (National Institutes of Health, Bethesda, MD, 331 
USA). Regarding lamina VII or IX, the number of contacts of BDA-labeled CST fibers 332 
with single Chx10-labeled neuron (Immunofluorescence) or single WGA-HRP-labeled 333 
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motoneurons (DAB staining) was analyzed at a magnification of x400, respectively. The 334 
contacts were defined by the presence of button-like swellings of BDA-labeled CST 335 
fibers on somas or dendrites. The result was normalized by the mean number of 336 
BDA-labeled CST fibers in the dorsolateral area at the C5 segment (three serial 337 
sections) on the SCI side. BDA-labeled CST fibers that were observed in the gray 338 
matter within a radius of 50 μm from the midline of the spinal cord on each of the SCI 339 
and non-SCI sides were counted as midline-crossing fibers from the ipsilateral and 340 
ventral CSTs (Fig. 5U). It should be noted here that such midline-crossing fibers may 341 
contain some of contralaterally sprouting CST fibers. The result was normalized by the 342 
mean number of BDA-labeled CST fibers in the dorsolateral area at each segment (three 343 
serial sections) on the non-SCI side. 344 
 345 
Measurements of the extent of spinal cord lesions 346 
The extent of spinal cord lesions was measured, with the ImageJ software 347 
described above, as the mean of the maximum lesioned area in three serial sections 348 
which were Nissl-stained with 1% Cresyl violet (see also Nakagawa et al., 2015). The 349 
lesioned area was expressed as the ratio to the total area of the hemi-transverse section 350 





For behavioral analyses of the control antibody-treated and anti-RGMa 354 
antibody-treated monkey groups, two-way ANOVA was applied. Increases in 355 
BDA-labeled CST fibers in laminae VII, IX and the midline area (i.e., midline-crossing 356 
CST fibers) were analyzed by two-way ANOVA, followed by Student’s t-test. For 357 
within-group comparisons for pre- versus post-muscimol injections in the 358 
reaching/grasping task and for the extent of spinal lesions, paired t-test was applied. All 359 






SCI model and the extent of spinal cord lesions 364 
In our SCI model, the spinal cord was unilaterally lesioned in macaque monkeys. 365 
The lesions were made at the border between the C6 and the C7 level to infringe upon 366 
the lateral area of the hemi-transverse section (Fig. 1A). When BDA was injected into 367 
the contralateral (contralesional) MI, laterally-situated CST fibers were found to be fully 368 
removed in all of the lesioned monkeys, and, therefore, no BDA-labeled CST fibers in 369 
any cases were observed in the dorsolateral funiculus of the spinal cord below the 370 
lesioned site (Figs. 1B-E,G-I and 2A; see also Fig. 5B,G,L). The lesioned sites in all SCI 371 
monkeys were Nissl-stained to assess the ratio of the lesioned area, and there was no 372 
marked difference between the control antibody-treated (control) monkey group and the 373 
anti-RGMa antibody-treated (RGMa antibody-treated) monkey group (Fig. 2A,B). Part 374 
of the medial gray matter was kept intact to retain a route of sprouting CST fibers in our 375 
SCI model, and anterograde tract-tracing with BDA from the contralesional MI resulted 376 
in CST fiber labeling in this area (Figs. 1C,D,F,H,J and 2A). To confirm cross-reaction 377 
of the anti-RGMa antibody to the MI and the spinal cord of rhesus monkeys, western 378 
blotting was performed. We observed double and triple bands in the monkey MI and 379 
spinal cord (Fig. 1M). It has been reported that the RGMa protein is a tethered 380 
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membrane-bound molecule, and that proteolytic processing amplifies RGMa diversity 381 
by creating soluble versions, the full-length and proteolytic cleavage RGMa, with 382 
long-range effects (Tassew et al., 2009, 2012). The antibody was delivered continuously 383 
to the lesioned site via the osmotic pump for four weeks immediately after SCI (Fig. 384 
1K,L,N). 385 
 386 
Upregulation of RGMa around the lesioned site after SCI 387 
First, the expression patterns of RGMa and Neogenin (a receptor for RGMs) 388 
were examined by immunohistochemistry or in situ hybridization in the cervical cord or 389 
MI, respectively, in our SCI model (one intact and two lesioned monkeys; Fig. 3). 390 
Longitudinal sections in the cervical cord ten days after SCI were immunostained with 391 
the anti-RGMa antibody, and then the RGMa expression was compared with a region 392 
remote from the lesioned site in the same section and with the same region in an intact 393 
(uninjured) section (Fig. 3A–C,F). Our immnunohistochemical analyses revealed that 394 
the RGMa expression was obviously increased around the lesioned site after SCI. Next, 395 
we characterized RGMa-expressing cells by double immunofluorescence histochemistry 396 
and found that RGMa was present in Iba1-positive cells (Fig. 3D–F). Thus, RGMa was 397 
expressed in microglia/macrophages and upregulated specifically around the lesioned 398 
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site. In addition, Neogenin was expressed in layer 5 (identified in the adjacent 399 
Nissl-stained sections) of the contralesional and ipsilesional MI (Fig. 3G–J). 400 
 401 
Effects of anti-RGMa antibody on impaired manual dexterity after SCI 402 
In the reaching/grasping task, the motor performance through both the 403 
vertical-slot and the horizontal-slot tasks was greatly recovered in the RGMa 404 
antibody-treated monkey group, compared with the control monkey group, to reach as 405 
highly as the pre-SCI level (Fig. 4C,D, Video S1). Similar results were obtained in the 406 
modified Brinkman board test, especially when the RGMa antibody-treated monkey 407 
group took out pellets from vertical slots (Fig. 4F,G, Video S2). In the case where skilled 408 
forelimb movements through the horizontal-slot task were attempted, the RGMa 409 
antibody-treated monkey group did not so prominently exhibit functional recovery, 410 
although motor behavior was improved in comparison with the control monkey group in 411 
which no such movements were restored at all (Fig. 4H, Video S2). Moreover, our 412 
behavioral analyses revealed that in both the reaching/grasping task and the modified 413 
Brinkman board test, the antibody treatment against RGMa not only promoted the 414 





Increase in sprouting CST fibers with the neutralizing antibody against RGMa 418 
To begin with addressing the reorganization of CST fibers below the lesioned 419 
site, we analyzed the distribution pattern of BDA-labeled CST fibers in the C7, C8, and 420 
Th1 segments. We observed no BDA-labeled CST fibers in the dorsolateral funiculus in 421 
both the control and the RGMa antibody-treated monkey groups (Fig. 5A,B,F,G,K,L). 422 
Approximately 30–50% of the BDA-labeled CST fibers, relative to an intact monkey, 423 
was found in lamina VII of the RGMa antibody-treated monkey group, whereas less 424 
than 10% of them were seen in lamina VII of the control monkey group (Fig. 425 
5A,C,F,H,K,M,P). In lamina IX, all WGA-HRP-labeled neurons corresponded with 426 
ChAT-positive motoneurons (Fig. 5D’), indicating that all of them are motoneurons for 427 
the median nerve. In the RGMa antibody-treated monkey group, the number of contacts 428 
of sprouting CST fibers with single WGA-positive neurons was increased in lamina IX 429 
below the lesioned site, compared with the control monkey group (Fig. 430 
5A,D,E,F,I,J,K,N,O,Q,E’). At least part of the sprouting CST fibers seemed to be in 431 
contact with spinal interneurons immunolabeled for Chx10. Similarly, we observed that 432 
the sprouting CST fibers in the RGMa antibody-treated monkey group appeared to make 433 
contact with single Chx10-positive neurons more frequently than in the control monkey 434 
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group (Fig. 5W-B’,C’). We found a certain difference in the reinnervation pattern of 435 
sprouting CST fibers in each segment. In lamina VII, the intensity of BDA-labeled CST 436 
fibers and the number of contacts of these CST fibers with single Chx10-positive 437 
neurons were gradually decreased as the distance from the lesioned site became larger 438 
(C7 < C8 < Th1) in the RGMa antibody-treated monkey group. By contrast, the number 439 
of contacts of sprouting CST fibers with single WGA-positive neurons was increased in 440 
the same group, which was similar to the findings in an intact monkey (Fig. 5P,Q,C’). 441 
The number of midline-crossing fibers was also increased by the neutralizing antibody 442 
against RGMa (Fig. 5R–V). It should be noted here that the midline-crossing fibers 443 
observed may involve some extended fibers from the injured CST. 444 
 445 
Impairments in recovered manual dexterity by muscimol inactivation in the 446 
contralesional MI 447 
Following all behavioral analyses, ICMS was performed in the contralesional 448 
and ipsilesional MI of both the control and the RGMa antibody-treated monkey groups 449 
whether the contralesional MI might contribute to the functional recovery from impaired 450 
manual dexterity due to SCI (Fig. 1N). The movements of the digits ipsilateral to SCI 451 
were successfully elicited by intracortical microstimulation in four loci of the 452 
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contralesional MI, but not of the ipsilesional MI in the RGMa antibody-treated SCI 453 
monkeys (Fig. 6A). Subsequent injections of muscimol into all of the 454 
electrophysiologically-identified digit region of the contralesional MI, but not of the 455 
ipsilesional MI, induced reversible impairments in skilled forelimb movements on the 456 
SCI side (Fig. 6C,D). The reaching/grasping task (for horizontal slots) was employed to 457 
assess the motor function. About 20 min after the muscimol injections, manual dexterity 458 
was gradually deteriorated and severely impaired within one hour. Thereafter, impaired 459 
forelimb movements were continually seen for a few hours. Although all RGMa 460 
antibody-treated monkeys could move the digits individually on the next day, manual 461 
dexterity was not so sufficiently restored, as compared to that before the muscimol 462 
injections into the contralesional MI. When we carried out the ICMS experiment in the 463 
control monkey group, no movements of the digits were evoked in the contralesional MI 464 
(Fig. 6B). In general, the digit region of the MI was surrounded by the regions 465 
representing the wrist, elbow, and face in macaque monkeys (Sessle and Wiesendanger, 466 
1982). However, a sector surrounded by the wrist, elbow, and face regions exhibited no 467 
response to ICMS (Fig. 6B). As we could not identify the digit region in the 468 
contralesional MI of the control monkey group, we injected muscimol only into the 469 
ipsilesional MI. Then, the muscimol injections into the digit region of the ipsilesional MI 470 
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induced reversible impairments in skilled movements of the SCI-unimpaired forelimb 471 
only on the uninjured side (Fig. 6E), just like the RGMa antibody-treated monkey group 472 





Owing to the low capacity of growth/regeneration in the mature CNS, various 476 
therapeutic approaches to CNS injures have been attempted against extrinsic and intrinsic 477 
inhibiting factors using in vivo and in vitro experiments with rodents (Sandvig et al., 478 
2004; Hata et al., 2006; Mar et al., 2014). According to previous works (Yiu and He, 479 
2006; Popovich and Longbrake, 2008; Rolls et al., 2009) glial cells expressing 480 
growth-inhibiting factors are rich in the lesioned area after SCI in rodents, and immune 481 
and inflammatory cells are also accumulated in the same area. It has repeatedly been 482 
demonstrated that RGMa is expressed in these cells (Schwab et al., 2005; Mirakaj et al., 483 
2010; Muramatsu et al., 2011). The present study revealed that RGMa was specifically 484 
upregulated around the lesioned site with increases in microglia/macrophages after SCI 485 
(see Fig. 3D,E). 486 
The spinal cord repair strategies through growing/regenerating axons include a 487 
series of events, consisting of the initiation of axonal growth, the maintenance of axonal 488 
elongation, the connectivity with appropriate target neurons, and the reorganization of 489 
neural circuitry (Bradbury and McMahon, 2006). In rodent SCI models, a 490 
reaching/grasping behavior was promoted by enhanced sprouting CST fibers, and many 491 
of these fibers were extended through the medial part of the spinal cord (Hollis et al., 492 
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2016). Thus, the enhanced sprouting CST fibers would make a synaptic connection with 493 
spinal interneurons as the target for restoration of forelimb functions in rodents. For a 494 
precision grip in higher primates, corticomotoneuronal pathway neurons in the MI are 495 
specifically activated (Muir and Lemon, 1983). Moreover, during the monkey’s 496 
performance of a pinching task, motor commands descending to spinal motoneurons are 497 
mediated at least partly by the spinal interneurons (Takei and Seki, 2010, 2013). Taken 498 
together, it is most likely that the reorganization of both the direct and the indirect (via 499 
the spinal interneurons) corticomotoneuronal pathways is required to promote recovery 500 
from impaired manual dexterity through enhanced sprouting of CST fibers in our SCI 501 
model. 502 
In our behavioral tasks, to take out pellets skillfully from vertical and horizontal 503 
slots, cortically-derived compensatory input would be transmitted to the motoneurons 504 
and/or interneurons in the C7, C8, and Th1 segments that are situated below the SCI site. 505 
Particularly when taking out a pellet from the horizontal slot in the modified Brinkman 506 
board test, the monkey is required to move the wrist to the ulnar direction for achieving 507 
digit flexion with ulnar deviation. It has been reported that the wrist angle in the ulnar 508 
direction is largely reduced after SCI when the monkey takes out a pellet from the 509 
horizontal slot (Hoogewoud et al., 2013). In macaque monkeys, spinal motoneurons 510 
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innervating the extensor carpi ulnaris muscle responsible for digit flexion with ulnar 511 
deviation are mainly distributed in the C8 and Th1 segments (Jenny and Inukai, 1983; 512 
Schieber, 1995). 513 
We demonstrated that sprouting CST fibers originating from the contralesional 514 
MI in RGMa antibody-treated monkeys penetrated more densely, compared with the 515 
control monkey group, into laminae VII and IX where spinal interneurons and 516 
motoneurons were located, respectively, below the lesioned site (see Fig. 5P,Q). In our 517 
experiments, the motoneurons in the C7, C8, and Th1 segments were labeled through 518 
the median nerve that predominantly governs the distal forelimb muscles, activity of 519 
which is essential for execution of manual dexterity with a precision grip (Dun et al., 520 
2007). In addition, a large number of motoneurons for hand (digits) muscles in primates 521 
are located in the Th1 segment (Jenny and Inukai, 1983). With respect to the pattern of 522 
reinnervation of the enhanced corticomotoneuronal pathway after SCI with the 523 
anti-RGMa antibody treatment, sprouting CST fibers might lead to appropriate target 524 
motoneurons with guidance factors to promote the recovery of motor functions 525 
effectively and efficiently. 526 
At least part of sprouting CST fibers seemed to be in contact with the 527 
interneurons immunolabeled for Chx10. Chx10 was originally identified as one of the 528 
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markers for glutamatergic interneurons in rodents (Ericson et al., 1997), and 529 
Chx10-positive neurons are reportedly distributed throughout the hindbrain and the 530 
spinal cord in mammals and regulate motor functions, such as breathing and locomotion 531 
(Ai-Mosawie et al., 2007; Crone et al., 2008, 2012; Dougherty and Kiehn, 2010; Azim 532 
et al., 2014). According to a recent work (Liu et al., 2015), there is a correlation between 533 
the number of Chx10-positive neurons in contact with sprouting CST fibers and 534 
functional recovery of the forelimb with unilateral cervical cord injury in mice. Together 535 
with the direct corticomotoneuronal pathway, the compensatory indirect pathway via 536 
spinal interneurons may also be crucial to the recovery of a series of forelimb 537 
movements, reaching for slots and taking out pellets from slots using a precision grip, in 538 
our SCI model. 539 
Interestingly, according to our behavioral analyses, the antibody treatment 540 
against RGMa not only promoted the recovery of motor functions, i.e., the ability to 541 
move the digits individually, but also advanced the start of recovery following SCI. It 542 
has been well documented that treatment with the RGMa-neutralizing antibody in a 543 
rodent model of multiple sclerosis promotes functional recovery by preventing 544 
neurodegeneration (Muramatsu et al., 2011; Tanabe and Yamashita, 2014; Demicheva et 545 
al., 2015). Recently, it has been reported that the RGMa antibody treatment promoted 546 
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neuronal survival around the lesioned site with improvement of functional recovery in a 547 
rodent SCI model (Mothe et al., 2017). Moreover, RGMa has been shown to reduce 548 
leukocyte trafficking and retard inflammation (Mirakaj et al., 2010). Thus, RGMa 549 
suppression has a certain impact on neuroprotection as well as on neurite outgrowth, 550 
and, therefore, the present results might be ascribed, at least partly, to the 551 
neuroprotective effect of the RGMa antibody. 552 
The spinal cord lesions in some cases (i.e., Ctrl-B and RGMa-A monkeys) 553 
infringed, to some extent, upon uncrossed ventral CST region, though it almost 554 
unaffected recovery of manual dexterity, especially in the RGMa antibody-treated 555 
(RGMa-A) monkey (data not shown). It has previously been reported that the ventral 556 
CST distributes the fibers to proximal muscles, such as the neck, trunk, and proximal 557 
upper extremities (Nyberg-Hansen, 1963; Davidoff, 1990; Canedo, 1997). The motor 558 
tasks that we used in the present work (i.e., reaching/grasping task and the modified 559 
Brinkman board test) are required for movements of the proximal upper limb, but the 560 
spinal region responsible for the proximal upper limb remains intact in our SCI model. 561 
By carrying out a series of pharmacological experiments following ICMS, we 562 
have demonstrated that the contralesional MI is greatly involved in recovery from 563 
impaired manual dexterity in our SCI model with the anti-RGMa antibody treatment. In 564 
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the control monkey group, on the other hand, forelimb movements once impaired by 565 
SCI could not be evoked at all by our ICMS protocol (44-pulse train, 65-µA current). 566 
This may depend on an increase in sprouting CST fibers from the contralesional MI to 567 
the cervical cord on the injured side. Additionally, it should be noted here that other 568 
descending pathways, including the cortico-brainstem and cortico-propriospinal 569 
pathways, might contribute to the functional recovery (Isa et al., 2013). In a similar 570 
primate model of SCI (C7/C8 lesion model), reorganization of CST fibers originating 571 
from the contralesional MI with the somatotopic map altered is crucial to recovery of 572 
motor functions (Schmidlin et al., 2004, 2005). Part of uncrossed CST fibers derived 573 
from the ipsilesional MI was disrupted in our SCI model, and, also, Neogenin was 574 
expressed in layer 5 of the ipsilesional MI as well as of the contralesional MI (see Fig. 575 
3I,J). RGMa has been shown to evoke the strong inhibition of axonal outgrowth and 576 
regrowth through the transmembrane receptor, Neogenin (Tassew et al., 2014). Hence, it 577 
can be considered that injured CST fibers extend beyond the lesioned site from the 578 
ipsilesional MI by the aid of the anti-RGMa antibody. However, the CST fibers arising 579 
from the ipsilesional MI may not work as a functional wiring at a late stage after SCI. In 580 
view of the fact that the ipsilesional MI is activated at an early, but not a late stage of 581 
recovery in a different primate model of SCI (Nishimura et al., 2007), the ipsilesional 582 
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MI might participate in functional restoration only transiently. 583 
The present study defines that RGMa is a critical target molecule to promote 584 
recovery from impaired manual dexterity after SCI. The antibody treatment against 585 
RGMa may probably be applied not only to SCI, but also to other CNS insults, such as 586 
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Figure legends 755 
Figure 1. SCI model and experimental time-course. 756 
(A) Schematic diagram showing our primate model of SCI. Unilateral lesions were made 757 
at a border between the C6 and the C7 segment. Asterisk indicates the lesioned site. (B) 758 
Example of the injection site in the contralesional MI. (C and G) Nissl-stained transverse 759 
sections in the injured (SCI) and uninjured spinal cords. The strongly stained area 760 
represents the lesion extent in panel C. (D and H) Transverse sections labeled with BDA 761 
injected into the contralesional or contralateral MI in the injured or uninjured spinal cord, 762 
respectively. The dotted line demarcates the lesioned area in panel D. (E and I) 763 
Higher-power magnifications of areas in the dorsolateral funiculus in panels D and H, 764 
respectively. (F and J) Higher-power magnifications of areas in the medial gray matter in 765 
panels D and H, respectively. Note that BDA-labeled CST fibers extend beyond the 766 
lesioned site through the intact medial gray matter in the injured spinal cord. (K) 767 
Schematic diagram showing the antibody delivery system using an osmotic pump. (L) 768 
Anti-RGMa antibody delivered around the lesioned site via an osmotic pump. To 769 
visualize the extent of antibody infusion, Fast blue was used. (M) Western blot analysis of 770 
the anti-RGMa antibody. The antibody crosses to the MI and the spinal cord of a rhesus 771 
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monkey. (N) Experimental time-course. Scale bars, B and C 1 mm for B to D and G, H, 772 
for B, C, E; J 50 μm for E, F, I and J. 773 
 774 
Figure 2. Extent of spinal cord lesions. 775 
(A) Extent of SCI (in blue) in a representative transverse section in each monkey. (B) 776 
Ratio of the lesioned area to the total area in a hemisection in each of control 777 
antibody-treated (Ctrl) and anti-RGMa antibody-treated (RGMa) monkeys. There is no 778 
marked difference in the averaged ratio between the two monkey groups. Because of the 779 
death by unknown accident shortly after the behavioral analyses, monkey RGMa-B was 780 
excluded from the electrophysiological/pharmacological and histological analyses. 781 
 782 
Figure 3. Expression patterns of RGMa and Neogenin in the cervical cord and MI. 783 
(A) RGMa expression (in purple) around the lesioned site (at the C6/C7 border) 10 days 784 
after SCI in a longitudinal section. Shown in black are CST fibers anterogradely labeled 785 
after BDA injections into the contralesional MI. (B) RGMa expression in a region 786 
remote from the lesioned site in the same section. (C) RGMa expression in the same 787 
region as in panel A in a normal (uninjured) case. (D and E) Expression of RGMa in 788 
combination with Iba1 around the lesioned site. (F) Schematic diagram representing the 789 
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approximate locations of panels A, B, D, and E. (G) In situ hybridization for Neogenin 790 
messenger RNA in layer 5 (V) of the contralesional MI 10 days after SCI in a frontal 791 
section. (H) Higher-power magnification of a square area in panel G. (I) In situ 792 
hybridization for Neogenin messenger RNA in layer 5 (V) of the ipsilesional MI 10 793 
days after SCI in a frontal section. (J) Higher-power magnification of a square area in 794 
panel I. Scale bars, A, 50 μm for A to C; D,G,I, 200 μm; E,H,J, 50 μm. 795 
 796 
Figure 4. Recovery from impaired manual dexterity with the neutralizing antibody 797 
against RGMa. 798 
(A and B) Reaching/grasping task. The monkey reaches for vertical (A) or horizontal (B) 799 
slots and grasps pellets. (C and D) Ratio of pellets collected through vertical (C) or 800 
horizontal (D) slots. (E) Modified Brinkman board test. The monkey takes out pellets 801 
from randomly-set vertical and horizontal slots. (F) Total number of pellets collected 802 
through vertical and horizontal slots. (G and H) Number of pellets collected through 803 
vertical (G) or horizontal (H) slots. All data are based on three control antibody-treated 804 
(Ctrl) and four anti-RGMa antibody-treated (RGMa) monkeys. Error bars denote S.E.M. 805 




Figure 5. Sprouting of CST fibers with the neutralizing antibody against RGMa. 808 
(A, F, and K) BDA-labeled CST fibers in the Th1 segment in an intact (Uninjured; A), a 809 
control antibody-treated (Ctrl; F) and an anti-RGMa antibody-treated (RGMa; K) 810 
monkey. (B, G, and L) Higher-power magnifications of areas of the dorsolateral 811 
funiculus in panels A, F, and K, respectively. (C, H, M, D, I, and N) Higher-power 812 
magnifications of areas of laminae VII (C, H, and M) and IX (D, I, and N) in panels A, F, 813 
and K, respectively. (E, J, and O) Higher-power magnifications of dotted zones in panels 814 
D, I, and N, respectively. (P) Intensity of BDA-labeled CST fibers in lamina VII in the 815 
intact (Uninjured; n = 1), control antibody-treated (Ctrl; n = 3), and anti-RGMa 816 
antibody-treated (RGMa; n = 3) monkey groups. (Q) Number of contacts of BDA-labeled 817 
CST fibers with single WGA-positive motoneurons in lamina IX in the same monkey 818 
groups as in panel P. (R, S, and T) BDA-labeled CST fibers crossing the midline of the 819 
spinal cord in an intact (Uninjured; R), a control antibody-treated (Ctrl; S), and an 820 
anti-RGMa antibody-treated (RGMa; T) monkey. BDA was injected into the 821 
contralateral or contralesional MI. (U) Schematic diagram showing the midline area 822 
examined. CC, central canal. (V) Number of midline-crossing CST fibers below the 823 
lesioned site (i.e., C7, C8, and Th1 segments). (W, Y, and A’) Spinal interneurons 824 
triple-labeled for BDA, NeuN, and Chx10 in lamina VII of the Th1 segment in an intact 825 
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(Uninjured; W), a control antibody-treated (Ctrl; Y), and an anti-RGMa antibody-treated 826 
(RGMa; A’) monkey. (X, Z, and B’) Higher-power magnifications of dotted zones in 827 
panels W, Y, and A’, respectively. BDA-labeled CST fibers in contact with single 828 
Chx10-positive neurons (specified by arrowheads). (C’) Number of contacts of 829 
BDA-labeled CST fibers with single Chx10-positive neurons in lamina VII in the same 830 
monkey groups as in panels P and Q. (D’) Motoneurons double-labeled for WGA-HRP 831 
through the median nerve and ChAT in lamina IX of the Th1 segment in an anti-RGMa 832 
antibody-treated monkey. All WGA-HRP-labeled neurons are ChAT-positive. The 833 
dotted line indicates the border between the gray and the white matter. (E’) Triple 834 
labeling for BDA, WGA-HRP, and VGluT1 in lamina IX of the Th1 segment in an 835 
anti-RGMa antibody-treated monkey. A BDA-labeled CST fiber in contact with a single 836 
WGA-positive motoneuron (specified by arrowheads). Scale bars, A, 1 mm for A,F,K; N, 837 
100 μm for B to D, G to I, L to N; O, 50 μm for E, J and O; R, 100 μm for R, S and T; W, 838 
200 μm for W, Y and A’; X and D’, 5 μm for X, Z, B’ and D’; C’, 200 μm. Error bars 839 
denote S.E.M. (two-way ANOVA, followed by Student’s t-test, *P < 0.05). 840 
 841 
Figure 6. Effects of muscimol injections into the MI on manual dexterity. 842 
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(A) Sites of muscimol injections into the contralesional and ipsilesional MI in a 843 
representative anti-RGMa antibody-treated monkey (RGMa-A). Filled circles indicate 844 
the injection loci in all of which ICMS induced movements of the digits on the 845 
contralateral side. AS, arcuate sulcus; CS, central sulcus. Scale bar, 2 mm. (B) Results of 846 
ICMS mapping of the contralesional MI in a representative control antibody-treated 847 
monkey (Ctrl-C). Each letter denotes the electrophysiologically-identified body part as 848 
follows: E, elbow; F, face; W, wrist; X, no response. Scale bar, 2 mm. (C–E) Skilled 849 
movements after muscimol injections into the digit region of the contralesional MI (C) or 850 
the ipsilesional MI (D) in the anti-RGMa antibody-treated monkey group (n = 3), or of the 851 
contralesional MI in the control antibody-treated monkey group (E; n = 3). Manual 852 
dexterity that had been impaired by SCI and then recovered by RGMa treatment 853 
(SCI-impaired forelimb) was again impaired after muscimol (but not saline) injections 854 
into the contralesional MI. On the other hand, the muscimol injections into the 855 
ipsilesional MI only caused impairments in skilled movements of the normal forelimb 856 
(SCI-unimpaired forelimb) contralateral to the injections. Error bars indicate S.E.M. 857 
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Video S1. Recovery process of the reaching/grasping task performance in a control 11 
antibody-treated and an anti-RGMa antibody-treated monkey. Fourteen weeks after SCI, 12 
the control antibody-treated monkey can manage to take out pellets from vertical and 13 
horizontal slots mainly using a power grip. On the other hand, the anti-RGMa 14 
antibody-treated monkey can take out at least some pellets from both types of the slots 15 
skillfully using a precision grip. 16 
 17 
Video S2. Recovery process of the modified Brinkman board test performance in a 18 
control antibody-treated and an anti-RGMa antibody-treated monkey. This movie shows 19 
that the monkeys take out pellets before, 3 days, and 14 weeks after SCI. Before SCI, 20 
the monkeys smoothly take out pellets from both the vertical and the horizontal slots. 21 
Just after SCI, the monkeys cannot take out any pellet at all. Fourteen weeks after SCI, 22 
the control antibody-treated monkey can take out some pellets only from the vertical 23 
slots. On the other hand, the anti-RGMa antibody-treated monkey can take out pellets 24 
not only from the vertical slots, but also from the horizontal slots. 25 
